Patents by Inventor Yingcai Wang

Yingcai Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070142384
    Abstract: The present invention provides compounds useful, for example, for modulating insulin levels in a subject and that have the general formula Q-L1-P-L2-M-X-L3-A wherein the definitions of the variables Q, L1, P, L2, M, X, L3 and A are provided herein. The present invention also provides compositions and methods for use of the compounds, for instance, for treatment of type II diabetes.
    Type: Application
    Filed: February 24, 2005
    Publication date: June 21, 2007
    Applicant: AMGEN INC.
    Inventors: Michelle Akerman, Jonathan Houze, Daniel Lin, Jinqian Liu, Jiwen Liu, Jian Luo, Zhihua Ma, Julio Medina, Wei Qiu, Jeffrey Reagan, Rajiv Sharma, Michael Schmitt, Stephen Shuttleworth, Ying Sun, Yingcai Wang, Jian Zhang, Liusheng Zhu
  • Publication number: 20070066647
    Abstract: The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I: where the definitions of the variables Q, L1, L2, M, X, L3, and A are provided herein. The present invention also provides compositions that include, and methods for using, the compounds in preparing medicaments and for treating metabolic disorders such as, for example, type II diabetes.
    Type: Application
    Filed: September 8, 2006
    Publication date: March 22, 2007
    Applicant: AMGEN ING.
    Inventors: Michelle Akerman, Sean Brown, Jonathan Houze, Jinqian Liu, Jiwen Liu, Zhihua Ma, Julio Medina, Wei Qiu, Michael Schmitt, Rajiv Sharma, Yingcai Wang, Liusheng Zhu
  • Publication number: 20060270724
    Abstract: The present invention provides compounds useful, for example, for modulating insulin levels in a subject, having the general formula I: wherein Q is an optionally substituted phenyl; L is a bond or O; P is a benzene or an optionally substituted thiazole ring; and R1 has the values provided herein. The present invention also provides compositions, uses, and methods for use of the compounds, for instance, for treatment of type II diabetes.
    Type: Application
    Filed: May 17, 2006
    Publication date: November 30, 2006
    Applicant: AMGEN INC
    Inventors: Jonathan Houze, Jiwen Liu, Zhihua Ma, Julio Medina, Michael Schmitt, Rajiv Sharma, Ying Sun, Yingcai Wang, Liusheng Zhu
  • Publication number: 20060004012
    Abstract: The present invention provides compounds useful, for example, for modulating insulin levels in a subject and that have the general formula Q-L1-P-L2-M-X-L3-A wherein the definitions of the variables Q, L1, P, L2, M, X, L3 and A are provided herein. The present invention also provides compositions and methods for use of the compounds, for instance, for treatment of type II diabetes.
    Type: Application
    Filed: February 25, 2005
    Publication date: January 5, 2006
    Inventors: Michelle Akerman, Jonathan Houze, Daniel Lin, Jiwen Liu, Jian Luo, Julio Medina, Wei Qiu, Jeffrey Reagan, Rajiv Sharma, Michael Schmitt, Stephen Shuttleworth, Ying Sun, Yingcai Wang, Jian Zhang, Liusheng Zhu
  • Publication number: 20040220237
    Abstract: Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment of inflammatory and immune-related diseases and conditions. In particular, the invention provides compounds which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer. The subject compounds are carboxylic acid derivatives.
    Type: Application
    Filed: December 19, 2003
    Publication date: November 4, 2004
    Inventors: Zice Fu, Alan Xi Huang, Jiwen Liu, Julio C. Medina, Michael J. Schmitt, H. Lucy Tang, Yingcai Wang, Qingge Xu